Cogent Biosciences Inc

NASDAQ:COGT   3:59:53 PM EDT
4.63
-0.13 (-2.73%)
Earnings Announcements

Cogent Biosciences Reports Recent Business Highlights And First Quarter 2022 Financial Results

Published: 05/10/2022 11:43 GMT
Cogent Biosciences Inc (COGT) - Cogent Biosciences Reports Recent Business Highlights and First Quarter 2022 Financial Results.
Cogent Biosciences Inc - Ended 1q 2022 With $191.0 Million in Cash, Sufficient to Fund Operations Into 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.65

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.62

More details on our Analysts Page.